Français
ItalianoBond AbbVie 5.4% ( US00287YDW66 ) in USD
| Issuer | AbbVie | ||||||||||||||||||
| Market price |  97.16 % ▼ |
||||||||||||||||||
| Country |  United States
|
||||||||||||||||||
| ISIN code |
 US00287YDW66 ( in USD )
|
||||||||||||||||||
| Interest rate | 5.4% per year ( payment 2 times a year) | ||||||||||||||||||
| Maturity | 15/03/2054 | ||||||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||||||
| Minimal amount | 2 000 USD | ||||||||||||||||||
| Total amount | 3 000 000 000 USD | ||||||||||||||||||
| Cusip | 00287YDW6 | ||||||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||||||||||||||
| Next Coupon | 15/09/2026 ( In 20 days ) | ||||||||||||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YDW66, pays a coupon of 5.4% per year. The coupons are paid 2 times per year and the Bond maturity is 15/03/2054 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YDW66, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YDW66, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||||||
| |||||||||||||||||||